8.35
6.76%
-0.605
アフターアワーズ:
8.35
Eyepoint Pharmaceuticals Inc (EYPT) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
16.71%
11.68
|
14.03 | 15.20 | 9.105 | 7.683 |
Cost Of Revenue |
0.759
|
- | - | - | - |
Gross Profit |
10.93
|
- | - | - | - |
Operating Expenses
|
45.63%
44.25
|
30.38 | 29.60 | 31.87 | 29.24 |
Interest Income/Expense |
-
|
- | - | 0.435 | 0.812 |
Benefits Costs and Expenses |
46.08%
40.97
|
28.04 | - | - | 28.85 |
Costs And Expenses |
60.48%
45.01
|
28.04 | 29.60 | 31.87 | 28.85 |
Operating Income/Loss |
103.75%
-33.32
|
-16.35 | -14.40 | -22.76 | -21.55 |
Nonoperating Income/Loss |
72.67%
4.037
|
2.338 | 1.786 | -0.159 | 0.39 |
Income/Loss From Continuing Operations Before Tax |
108.93%
-29.28
|
-14.02 | 15.20 | 9.105 | -21.16 |
Income/Loss From Continuing Operations After Tax |
107.70%
-29.28
|
-14.10 | -12.61 | -22.92 | -21.16 |
Net Income/Loss
|
107.70%
-29.28
|
-14.10 | -12.61 | -22.92 | -21.16 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
95.19%
0.0529
|
1.10 | 38.34 | 37.58 | 37.49 |
Diluted Average Shares |
95.19%
0.0529
|
1.10 | 38.34 | 37.58 | 37.49 |
Basic Earnings Per Share |
71.87%
-0.55
|
-0.32 | -0.33 | -0.61 | -0.56 |
Diluted Earnings Per Share |
71.87%
-0.55
|
-0.32 | -0.33 | -0.61 | -0.56 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):